文献速递血栓与止血

急性内科住院患者静脉血栓栓塞症风险评估模型的验证:一项队列研究

Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort study.
PubMed 文献 · J Thromb Haemost · 2020-04-16

本研究基于PREVENU试验的前瞻性队列进行回顾性分析,在14 660例40岁以上内科住院患者中评估Caprini、IMPROVE和Padua评分对3个月内症状性VTE或不明原因猝死的预测效能。三种评分的AUC分别为0.60、0.63和0.64,均未显著优于单独使用年龄(AUC 0.61), discriminative ability较差。

要点

  • Caprini、IMPROVE和Padua评分对内科住院患者VTE的区分能力较差,AUC均≤0.64。
  • 三种评分均未显著优于单独使用年龄作为预测指标(AUC 0.61)。
  • Padua和Caprini评分所需的BMI在44%患者中缺失,可能影响评分应用。

核心结论

  • Caprini、IMPROVE和Padua评分对非危重内科住院患者VTE的区分能力较差,且不优于单独基于年龄的风险评估。

研究设计与样本

  • 对PREVENU试验中前瞻性入组的患者进行回顾性分析,纳入40岁及以上、内科病房住院至少2天者,随访3个月。
  • 共14 910例合格患者,14 660例可评估;排除入院48小时内诊断VTE、接受全剂量抗凝或手术患者及危重患者。

主要发现

  • 3个月随访期间,1.8%的患者发生症状性VTE或不明原因猝死。
  • Caprini、IMPROVE和Padua评分的AUC分别为0.60(95%CI 0.57-0.63)、0.63(95%CI 0.60-0.66)和0.64(95%CI 0.61-0.67)。
  • 年龄单独作为预测指标的AUC为0.61(95%CI 0.58-0.64),三种评分均未显著优于年龄。

临床怎么用

  • 对于非危重内科住院患者,现有VTE风险评估模型(Caprini、IMPROVE、Padua)的区分能力有限,临床决策时需谨慎解读评分结果。
  • 年龄可能是一个简单有效的VTE风险预测因素,但需进一步研究验证。

局限性

  • 回顾性评估评分,Padua和Caprini评分所需的BMI在44%患者中缺失。
  • 研究排除危重患者、入院48小时内诊断VTE者、接受全剂量抗凝或手术患者,结论外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Because hospital-acquired venous thromboembolism (VTE) represents a frequent cause of preventable deaths in medical inpatients, identifying at-risk patients requiring thromboprophylaxis is critical. We aimed to externally assess the Caprini, IMPROVE, and Padua VTE risk scores and to compare their performance to advanced age as a stand-alone predictor. METHODS: We performed a retrospective analysis of patients prospectively enrolled in the PREVENU trial. Patients aged 40 years and older, hospitalized for at least 2 days on a medical ward were consecutively enrolled and followed for 3 months. Critical ill patients were not recruited. Patients diagnosed with VTE within 48 hours from admission, or receiving full dose anticoagulant treatment or who underwent surgery were excluded. All suspected VTE and deaths occurring during the 3-month follow-up were adjudicated by an independent committee. The three scores were retrospectively assessed. Body mass index, needed for the Padua and Caprini scores, was missing in 44% of patients. RESULTS: Among 14 910 eligible patients, 14 660 were evaluable, of which 1.8% experienced symptomatic VTE or sudden unexplained death during the 3-month follow-up. The area under the receiver operating characteristic curves (AUC) were 0.60 (95% confidence interval [CI] 0.57-0.63), 0.63 (95% CI 0.60-0.66) and 0.64 (95% CI 0.61-0.67) for Caprini, IMPROVE, and Padua scores, respectively. None of these scores performed significantly better than advanced age as a single predictor (AUC 0.61, 95% CI 0.58-0.64). CONCLUSION: In our study, Caprini, IMPROVE, and Padua VTE risk scores have poor discriminative ability to identify not critically ill medical inpatients at risk of VTE, and do not perform better than a risk evaluation based on patient's age alone.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Moumneh T, Riou J, Douillet D, et al. Validation of risk assessment models predicting venous thromboembolism in acutely ill medical inpatients: A cohort study. J Thromb Haemost. 2020. PMID: 32168402. doi:10.1111/jth.14796

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。